Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease

Journal of Biological Regulators and Homeostatic Agents

Volumn 25, Issue 1, 2011, Pages 47-56

  Tarantino, Giovanni ^a   Colao, A ^a   Capone, D ^a   Conca, P ^a   Tarantino, M ^a   Grimaldi, E ^a   Chianese, D ^a   Finelli, C ^a   Contaldo, F ^a   Scopacasa, F ^a   Savastano, S ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Apoptosis; Cytochrome C; Gamma glutamyl transferase; NAFLD; Triglycerides; Unconiugated bilirubin

Indexed keywords

BILIRUBIN; CYTOCHROME C; GAMMA GLUTAMYLTRANSFERASE; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADULT; AGED; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; ULTRASOUND; ADOLESCENT; BLOOD; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FATTY LIVER; METABOLISM; MITOCHONDRION; OXIDATIVE STRESS; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; BILIRUBIN; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; CYTOCHROMES C; FATTY LIVER; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; MITOCHONDRIA; OBESITY; OXIDATIVE STRESS; RETROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 79955700474     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Tarantino G, Conca P, Pasanisi F, Ariello M, Mastrolia M, Arena A, Tarantino M, Scopacasa F, Vecchione R. Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur J Gastroenterol Hepatol 2009; 21:504-11.
2. Tarantino G, Conca P, Riccio A, et al. Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign? J Transi Med 2008; 6:72.
3. Pardina E, Baena-Fustegueras JA, Llamas R, et al. Lipoprotein lipase expression in livers of morbidly obese patients could be responsible for liver steatosis. Obes Surg 2009; 19:608-16.
4. Brookheart RT, Michel CI, Schaffer JE. As a matter of fat. Cell Metab 2009; 10:9-12.
5. Frith J, Day CP, Henderson E, Burt AD, Newton JL. Non-alcoholic fatty liver disease in older people. Gerontology 2009; 55:607-13.
6. Ekstedt M, Franzen LE, Mathiensen UI, Thorelius L, Holmqvist M, Bodemar G, Kechagias S. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006; 44:865-73. (Pubitemid 46489550)
7. Malhi H, Bronk SF, Werneburg NW, Gores GJ. Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J Biol Chem 2006; 281:12093-101. (Pubitemid 43855473)
8. Renz A, Berdel WE, Kreuter M, Belka C, Schulze-Osthoff K, Los M. Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. Blood 2002; 98:1542-8.
9. Adachi N, Hirota M, Hamaguchi M, Okamoto K, Watanabe K, Endo F. Serum cytochrome c level as a prognostic indicator in patients with systemic inflammatory response syndrome. Clin Chim Acta 2004; 342:127-36. (Pubitemid 38352921)
10. Alleyne T, Joseph J, Sampson V. Cytochrome-c detection: a diagnostic marker for myocardial infarction. Appl Biochem Biotechnol 2001; 90:97-105. (Pubitemid 32225483)
11. Barczyk K, Kreuter M, Pryjma J, Booy EP, Maddika S, Ghavami S, Berdel WE, Roth J, Los M. Serum cytochrome c indicates in vivo apoptosis and can serve as a prognostic marker during cancer therapy. Int J Cancer 2005; 116:167-73. (Pubitemid 40967251)
12. Ben-Ari Z, Schmilovotz-Weiss H, Belinki A, et al. Circulating soluble cytochrome c in liver disease as a marker of apoptosis. J Intern Med 2003; 254:168-175. (Pubitemid 36900440)
13. André P, Balkau B, Vol S, Charles MA, Eschwège E; DESIR Study Group. Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort. Diabetes Care 2007; 30: 2355-61. (Pubitemid 47364644)
14. Lee DH, Blomhoff R, Jacobs DR, Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 2004; 38:535-9. (Pubitemid 38697087)
15. Langford MP, Redens TB, Harris NR, Lee S, Jain SK, Reddy S, McVie R. Plasma levels of cell-free apoptotic DNA ladders and gamma- glutamyltranspeptidase (GGT) in diabetic children. Exp Biol Med 2007; 232:1160-9. (Pubitemid 47503057)
16. Tell G, Gustincich S. Redox state, oxidative stress, and molecular mechanisms of protective and toxic effects of bilirubin on cells. Curr Pharm Des 2009; 15:2908-14.
17. Kohli R, Pan X, Malladi P, Wainwright MS, Whitington PF. Mitochondrial reactive oxygen species signal hepatocyte steatosis by regulating the phosphatidylinositol 3-kinase cell survival pathway. J Biol Chem 2007; 282:21327-36. (Pubitemid 47099964)
18. Webb M, Yeshua H, Zelber-Sagi S, Santo E, Brazowski E, Halpern Z, Oren R. Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. AJR Am J Roentgenol 2009; 192:909-14.
19. Mason C, Katzmarzyk PT. Variability in waist circumference measurements according to anatomic measurement site. Obesity 2009; 17:1789-1795.
20. Kleiner DE, Brunt EM, Van Natta M, et al. Nonalcoholic Steatohepatitis Clinical Research Network Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41:1313-21. (Pubitemid 40770284)
21. Dincer Y, Himmetoglu S, Yalin S, Damci T, Ilkova H, Akcay T. Serum levels of p53 and cytochrome c in subjects with type 2 diabetes and impaired glucose tolerance. Clin Invest Med 2009; 32:E266-270.
22. Dincer Y, Himmetoglu S, Bozcali E, Vural VA, Akcay T. Circulating p53 and cytochrome c levels in acute myocardial infarction patients. J Thromb Thrombolysis 2010; 29:41-5.
23. Ramalho RM, Cortez-Pinto H, Castro RE, Sola S, Costa A, Moura MC, Camilo ME, Rodrigues CM. Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis. Eur J Gastroenterol Hepatol 2006; 18:21-29. (Pubitemid 43004877)
24. Takahashi R, Deveraux Q, Tamm I, Welsh K, Assa-Munt N, Salvesen GS, Reed JC. A single BIR domain of XIAP sufficient for inhibiting caspases. J Biol Chem 1998; 273:7787-90. (Pubitemid 28168819)
25. Lakhani SA, Masud A, Kuida K, Porter GA, Booth C J, Mehal WZ, Inayat I, Flavell RA. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 2006; 311:847-51. (Pubitemid 43228848)
26. Yilmaz Y. Systematic review: caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease. Aliment Pharmacol Ther 2009; 30:1103-09.
27. Murray TV, McMahon JM, Howley BA, Stanley A, Ritter T, Mohr A, Zwacka R, Fearnhead HO. A non-apoptotic role for caspase-9 in muscle differentiation. J Cell Sci 2008; 121:3786-93.
28. Tuominen EKJ, Wallace CJA, Kinnunen, PKJ. Phospholipid-cytochrome c interaction. Evidence for the extended lipid anchorage. J Biol Chem 2002; 277:8822-6. (Pubitemid 34952948)
29. Cummings C, Walder J, Treeful A, Jemmerson R. Serum leucine-rich alpha-2-glycoprotein-1 binds cytochrome c and inhibits antibody detection of this apoptotic marker in enzyme-linked immunosorbent assay. Apoptosis 2006; 11:1121-9. (Pubitemid 44035961)
30. Iłzecka J. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis. Scand J Clin Lab Invest 2007; 67:264-9. (Pubitemid 46643380)
31. Tahan V, Canbakan B, Balci H, et al. Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk. Hepatogastroenterology 2008;55:1433-8.
32. Kawasaki H, Murawaki Y, Kimura N, Hirayama C. Effects of phenobarbital on unconjugated bilirubin clearance, gamma-glutamyltranspeptidase and urinary d-glucaric acid in patients with Gilbert's syndrome. Hepatogastroenterology 1982; 29:252-5. (Pubitemid 13065522)
33. Henery S, George T, Hall B, Basiji D, Ortyn W, Morrissey P. Quantitative image based apoptotic index measurement using multispectral imaging flow cytometry: a comparison with standard photometric methods. Apoptosis 2008; 13:1054-63.
34. Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem 1997; 43:1209-14. (Pubitemid 27297265)
35. Tarantino G, Saldalamacchia G, Conca P, Arena A. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. J Gastroenterol Hepatol 2007; 22:293-303. (Pubitemid 46238755)